Literature DB >> 21698724

Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.

Jinjun Shi1, Zeyu Xiao, Alexander R Votruba, Cristian Vilos, Omid C Farokhzad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21698724      PMCID： PMC3515655          DOI： 10.1002/anie.201101554

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  29 in total

1.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

2.  O-ethylphosphatidylcholine: A metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent.

Authors:  R C MacDonald; V A Rakhmanova; K L Choi; H S Rosenzweig; M K Lahiri
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

3.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles.

Authors:  Shyh-Dar Li; Yun-Ching Chen; Michael J Hackett; Leaf Huang
Journal:  Mol Ther       Date:  2007-10-09       Impact factor: 11.454

4.  The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

Authors:  Mark E Davis
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 5.  Lipid-based systemic delivery of siRNA.

Authors:  Yu-Cheng Tseng; Subho Mozumdar; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2009-03-26       Impact factor: 15.470

6.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

Authors:  Liangfang Zhang; Juliana M Chan; Frank X Gu; June-Wha Rhee; Andrew Z Wang; Aleksandar F Radovic-Moreno; Frank Alexis; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

7.  Hydrophobic moiety of cationic lipids strongly modulates their transfection activity.

Authors:  Rumiana Koynova; Boris Tenchov; Li Wang; Robert C Macdonald
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

8.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.

Authors:  Akin Akinc; Andreas Zumbuehl; Michael Goldberg; Elizaveta S Leshchiner; Valentina Busini; Naushad Hossain; Sergio A Bacallado; David N Nguyen; Jason Fuller; Rene Alvarez; Anna Borodovsky; Todd Borland; Rainer Constien; Antonin de Fougerolles; J Robert Dorkin; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Matthias John; Victor Koteliansky; Muthiah Manoharan; Lubomir Nechev; June Qin; Timothy Racie; Denitza Raitcheva; Kallanthottathil G Rajeev; Dinah W Y Sah; Jürgen Soutschek; Ivanka Toudjarska; Hans-Peter Vornlocher; Tracy S Zimmermann; Robert Langer; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2008-04-27       Impact factor: 54.908

9.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.

Authors:  Maha Saad; Olga B Garbuzenko; Tamara Minko
Journal:  Nanomedicine (Lond)       Date:  2008-12       Impact factor: 5.307

10.  Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.

Authors:  Carolina Salvador-Morales; Liangfang Zhang; Robert Langer; Omid C Farokhzad
Journal:  Biomaterials       Date:  2009-01-23       Impact factor: 12.479
View more
  36 in total

1.  In vivo sustained release of siRNA from solid lipid nanoparticles.

Authors:  Tatsiana Lobovkina; Gunilla B Jacobson; Emilio Gonzalez-Gonzalez; Robyn P Hickerson; Devin Leake; Roger L Kaspar; Christopher H Contag; Richard N Zare
Journal:  ACS Nano       Date:  2011-11-18       Impact factor: 15.881

Review 2.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

3.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

Review 4.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

5.  Fabrication of electrospun zein nanofibers for the sustained delivery of siRNA.

Authors:  K Karthikeyan; Venkat Raghavan Krishnaswamy; Rachita Lakra; M S Kiran; Purna Sai Korrapati
Journal:  J Mater Sci Mater Med       Date:  2015-02-06       Impact factor: 3.896

6.  Microfluidic based high throughput synthesis of lipid-polymer hybrid nanoparticles with tunable diameters.

Authors:  Qiang Feng; Lu Zhang; Chao Liu; Xuanyu Li; Guoqing Hu; Jiashu Sun; Xingyu Jiang
Journal:  Biomicrofluidics       Date:  2015-06-23       Impact factor: 2.800

Review 7.  Composite nanoparticles for gene delivery.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

8.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

9.  Development of multinuclear polymeric nanoparticles as robust protein nanocarriers.

Authors:  Jun Wu; Nazila Kamaly; Jinjun Shi; Lili Zhao; Zeyu Xiao; Geoffrey Hollett; Rohit John; Shaunak Ray; Xiaoyang Xu; Xueqing Zhang; Philip W Kantoff; Omid C Farokhzad
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

10.  Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors.

Authors:  Aditya Kulkarni; Kyle DeFrees; Ryan A Schuldt; Alexander Vlahu; Ross VerHeul; Seok-Hee Hyun; Wei Deng; David H Thompson
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.